“You’re almost glancing behind a curtain”: HIV care provider perceptions regarding integration and value of pre-visit electronic tablet-based patient-reported outcomes data collection in two North American clinics Creative Commons
Link for citation this article

Rob Fredericksen,

Duncan Short,

Emma Fitzsimmons,

Divya Korlipara,

Shivali Suri,

Moti Ramgopal,

Brenda Jacobs,

Jean Bacon,

Abigail Kroch,

Alexandra Musten,

Vincent Hodge,

Darrell Tan,

Jeff Berry,

Deborah Yoong,

Mark Naccarato,

Kevin Gough,

Justin Mcreynolds,

William Lober,

Heidi Crane

Journal of AIDS and HIV Research, Journal Year: 2022, Volume and Issue: Vol.14(1), P. 22 - 31

Published: Jan. 1, 2022

This study was conducted to assess provider perceptions regarding value of tablet-based patient-reported outcome (PRO) assessments in routine care. Patients self-administered a brief PRO assessment of several clinical domains on-site prior to HIV clinic visits. Providers were given succinct summary results. 1:1 interviews were conducted with providers regarding PROs utility and their integration into care, and coded interview transcripts into thematic areas. Providers described how PROs helped prioritize topics for discussion during the visit, and facilitated their identification and ability to address sensitive issues, particularly depression/suicidality, sexual behavior, and intimate partner violence. PROs further facilitated comprehensive identification of other issues …

Medical treatment of the complication of first trimester pregnancy loss with misoprostol Creative Commons
Link for citation this article

Naushaba Rizwan,

Syed Farhan Uddin

International Journal of Medicine and Medical Sciences, Journal Year: 2014, Volume and Issue: Vol.6(9), P. 211 - 214

Published: Sept. 30, 2014

The objective of the study was to evaluate the efficacy of misoprostol in patients with complication of first trimester pregnancy loss. After the departmental approval, a total of 102 women with first trimester pregnancy failure were recruited for treatment with misoprostol. The inclusion criteria were gestational age of less than 12 weeks and hemodynamically stable. The exclusion criteria were patients with history of hypersensitivity to prostaglandin, bronchial asthma and hemoglobin less than 9 g. Main outcome measures were the successful resolution of miscarriages without surgical intervention; secondary outcomes were incidence of pain, vaginal bleeding, infection, pyrexia and gastrointestinal side effects. …